Exchange: NASDAQ·Updated 09:42 AM EDT

LTGO Latigo Biotherapeutics Inc.

$23.21
$0.73
(3.25%)
Today
Mkt Cap$1.42B
Vol816.00

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded by Bryan Moyer on November 20, 2018 and is headquartered in Thousand Oaks, CA.
27

Bearish Sentiment

How do you feel about LTGO?

Advertisement|Remove ads.